Whalen Wealth Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$243K Buy
+2,129
New +$251K 0.1% 188
2026
Q2
– Sell
-2,969
Closed -$485K – 207
2026
Q1
$485K Buy
+2,969
New +$456K 0.26% 98
2025
Q3
– Sell
-2,832
Closed -$285K – 221
2025
Q2
$285K Sell
2,832
-13
-0.5% -$994 0.18% 143
2025
Q1
$217K Buy
+2,845
New +$218K 0.14% 114

Other funds holding INSM

Whalen Wealth Management's INSM Position: Q3 2026 in Review

Whalen Wealth Management opened a new position in Insmed (INSM) in Q3 2026: 2,129 shares worth $243K. The stake represents 0.1% of the portfolio and ranks #188 among its holdings. This is a return to the name: Whalen Wealth Management previously reported a position in INSM as recently as Q1 2026.

Whalen Wealth Management first reported a position in INSM in Q1 2025 and has held it in 4 quarters since. The position peaked at $485K in Q1 2026. 16 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Whalen Wealth Management held 2,129 shares of Insmed worth $243K as of Q3 2026.
  • Insmed was a new Whalen Wealth Management position in Q3 2026.
  • Insmed made up 0.1% of Whalen Wealth Management's portfolio in Q3 2026, its #188 holding.
  • Whalen Wealth Management first reported a position in Insmed in Q1 2025 and has held it in 4 quarters since.
  • Whalen Wealth Management's Insmed position peaked at $485K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Whalen Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.